Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Orthop Trauma Surg ; 130(10): 1201-7, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19830440

RESUMO

INTRODUCTION: Lindgren-Turan osteotomy used in hallux valgus deformity is a subcapital, transverse displacement osteotomy of the first metatarsal without any additional capsular repair. The aims of this study are to describe a transosseous capsuloplasty technique in this procedure and evaluate whether capsuloplasty would improve the clinical and radiological outcomes in patients with moderate to severe hallux valgus deformity. METHODS: Twenty-three feet operated by Lindgren-Turan osteotomy (Group B) and 25 feet operated by the same osteotomy combined with transosseous capsuloplasty (Group A) were evaluated retrospectively for the correction of the hallux valgus, intermetatarsal and distal metatarsal articular angles, sesamoid reduction, American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating Scale as well as patient satisfaction. The mean postoperative follow-up was 14 (range 12-28) months. RESULTS: All radiological parameters improved considerably as a result of both groups. However, postoperative improvements in intermetatarsal and distal metatarsal articular angles were greater in Group A. Complete reduction of medial sesamoid was achieved in 52% of patients in Group A, whereas 17.4% of patients in Group B had complete reduction. AOFAS scores and number of patients with complete satisfaction in Group A were significantly greater than that in Group B. CONCLUSION: Better clinical and radiological outcomes can be achieved in patients with moderate to severe hallux valgus deformity operated by Lindgren-Turan distal metatarsal osteotomy, when it combines with transosseous capsuloplasty.


Assuntos
Hallux Valgus/cirurgia , Cápsula Articular/cirurgia , Ossos do Metatarso/cirurgia , Articulação Metatarsofalângica/cirurgia , Osteotomia/métodos , Adulto , Idoso , Parafusos Ósseos , Feminino , Hallux/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
2.
Acta Orthop Traumatol Turc ; 42(5): 322-7, 2008.
Artigo em Turco | MEDLINE | ID: mdl-19158452

RESUMO

OBJECTIVES: We investigated risk factors for venous thromboembolism (VTE), prophylaxis measures employed, and incidence of symptomatic deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing major orthopaedic surgery (MOS). METHODS: An open, multicenter, prospective, observational study was conducted in 21 medical centers, comprising 899 patients. Of these, 316 patients (35.2%) underwent total hip arthroplasty (THA), 328 patients (36.5%) underwent total knee arthroplasty (TKA), and 255 patients (28.4%) underwent surgery for hip fractures (HF). Pharmacologic prophylaxis was employed in all the patients. RESULTS: Risk factors for VTE were seen in 73.2% of the patients, the most common being obesity (72%) and prolonged immobilization (36.3%). Low-molecular-weight heparin (91.1%) and fondaparinux (8.9%) were used for prophylaxis, which was short-term in 273 patients (30.4%) and long-term in 626 patients (69.6%). Mechanical prophylaxis was performed with compression stockings in 610 patients (67.9%) and by intermittent pneumatic compression in 67 patients (7.5%). During three-months of follow-up, symptomatic DVT and PE were seen in eight (0.9%) and four patients (0.4%), respectively. Mortality occurred in 10 patients (1.1%). Complications of major and minor bleeding were seen in eight (0.9%) and 40 (4.5%) patients, respectively. CONCLUSION: Effective VTE prophylaxis is associated with low risk of clinically apparent DVT and PE in MOS.


Assuntos
Anticoagulantes/uso terapêutico , Procedimentos Ortopédicos/efeitos adversos , Embolia Pulmonar/prevenção & controle , Tromboembolia Venosa/prevenção & controle , Idoso , Artroplastia de Quadril/efeitos adversos , Artroplastia do Joelho/efeitos adversos , Feminino , Fondaparinux , Heparina de Baixo Peso Molecular/uso terapêutico , Fraturas do Quadril/cirurgia , Humanos , Imobilização/efeitos adversos , Masculino , Pessoa de Meia-Idade , Obesidade/complicações , Polissacarídeos/uso terapêutico , Estudos Prospectivos , Embolia Pulmonar/epidemiologia , Embolia Pulmonar/mortalidade , Fatores de Risco , Tromboembolia Venosa/epidemiologia , Tromboembolia Venosa/mortalidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...